Dysregulation of IL-6 and TGF-β1 has been linked to an array of inflammatory and pathologic conditions including atherosclerosis, Alzheimer disease, and rheumatoid arthritis [45-52]. This evidence concerns the gene TGFB1 and atherosclerosis.